MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 881 to 900 of 166,322 approvalsPage 45 of 8317

小儿咳喘灵颗粒

Approval Number: 国药准字Z41020482
Registration: Apr 7, 2025

Aminophylline Injection

Approval Number: 国药准字H20258057
Registration: Apr 7, 2025

宁神补心片

Approval Number: 国药准字Z41022280
Registration: Apr 7, 2025

Vecuronium Bromide for Injection

Approval Number: 国药准字H20258055
Registration: Apr 7, 2025

Cefoperazone Sodium and Sulbactam Sodium for Injection

Approval Number: 国药准字H20258056
Registration: Apr 7, 2025

盐酸托泊替康

Approval Number: 国药准字H20000427
Registration: Apr 3, 2025

Compound Calcium Corbonate Effervescent Tablets

Approval Number: 国药准字H52020513
Registration: Apr 3, 2025

蛤蚧大补丸

Approval Number: 国药准字Z44020698
Registration: Apr 3, 2025

Ambroxol Hydrochloride Oral Solution

Approval Number: 国药准字H20258053
Registration: Apr 3, 2025

羟喜树碱

Approval Number: 国药准字H52020626
Registration: Apr 3, 2025

Quetiapine Fumarate Tablets

Approval Number: 国药准字H20258052
Registration: Apr 2, 2025

Quetiapine Fumarate Tablets

Approval Number: 国药准字H20258051
Registration: Apr 2, 2025

Fusidic Acid Cream

Approval Number: 国药准字HC20150044
Registration: Apr 2, 2025

Fusidic Acid Cream

Approval Number: 国药准字HC20150043
Registration: Apr 2, 2025

Glucosamine Sulfate Capsules

Approval Number: 国药准字H20253770
Registration: Apr 1, 2025

Peramivir Injection

Approval Number: 国药准字H20253769
Registration: Apr 1, 2025

Dapagliflozin Tablets

Approval Number: 国药准字H20253782
Registration: Apr 1, 2025

Beclometasone Dipropionate Suspension for Inhalation

Approval Number: 国药准字H20253765
Registration: Apr 1, 2025

Compound Amino Acids Injection(18AA-Ⅶ)

Approval Number: 国药准字H20253761
Registration: Apr 1, 2025

Cilostazol Tablets

Approval Number: 国药准字H20253783
Registration: Apr 1, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.